Medical Dynamics

Partnering Inflammation/Autoimmune Drugs Offers Sizzle And Steak (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

BioMarin treatment gets special FDA status (CNBC)

US Senate health reform battle begins (PharmaTimes)

Read the rest of this entry »

Merck Wins Second Fosamax Trial After Questioning Qualifications Of Expert Witness (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Idera, Novartis deal ends; Merck deal extended (Mass High Tech)

Johnson & Johnson Focused Funding Grant for Parkinson’s Research (Newswise)

Read the rest of this entry »

• Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries (Press release issued by Gilead)

• Novartis Opens 1st US Plant (VIDEO – CNBC)

• Bioform Medical to Present at the 21st Annual Piper Jaffray Health Care Conference (Press release issued by BioForm Medical)

Read the rest of this entry »

• “Novartis Pediatric Post-Market Plans For Xolair Fall Short Of FDA Request” (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

• “Part D Coverage Gap Relief Added To Senate Health Reform Bill; Is It Enough?” (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

• “BEFORE THE BELL-Cephalon drops after Cinquil trial results” (Reuters)

Read the rest of this entry »

UPDATE 2-US panel backs new claim for Pfizer lung drug (Reuters)

FDA Panel Rejects Cell Culture Flu Vaccine, Wants More Safety Data (MedPage Today)

Breast Cancer Screening: New Fuel for an Old War of Words and Data (MedPage Today)

Read the rest of this entry »

House Leaders Seek GAO Review Of Possible “Anticipatory Price Gouging” By Drug Firms (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

AstraZeneca’s Brilinta filed in the USA (PharmaTimes.com)

US regulator wants more information on Rituxan for CLL (PharmaTimes.com)

Read the rest of this entry »

Health Care Reform Could Be In Critical Condition If Senate Doesn’t Vote By Christmas, Daschle Says (The Pink Sheet)

This is copyright protected information, to receive the full article, please click here to sign up and register.

AVI BioPharma, Inc. to Present at Transformational Medical Technologies Initiative (TMTI) Industry Day (CNN Money)

Pfizer taking more targeted approach to R&D (PharmaTimes.com)

Read the rest of this entry »

Panel Puts Off Mammography until Age 50 (MedPage Today)

AHA: Tripling ARB Dose Improves HF Outcomes (MedPage Today)

GSK signs nicotine vaccine deal with Nabi worth over $540 million (PharmaTimes.com)

Read the rest of this entry »

US Justice Dept warns pharma over foreign “bribes” (PharmTimes.com)

Merck stands by Zetia as small study favours Abbott’s Niaspan (PharmaTimes.com)

The Medicines Company CHAMPIONs benefits of cangrelor (PharmTimes.com)

Read the rest of this entry »

Abbott/Pan Genetics pact could be worth $190 million (PharmaTimes.com)

Roflumilast Shows Strong Efficacy In Symptomatic COPD (Health News Daily)

Special Medical Liaisons Are No Back Door To Off-Label Promotion- Experts (Health News Daily)

Read the rest of this entry »